Released Nov 7, 2017, after the close
10-Q filed Nov 7, 2017, 38 days after period end · 0001162194-17-000159
Q3 2017 · 10-Q
Revenue$24.75M$24.75M +11.5% vs Q3 2016+3.5% vs Q2 2017
Net Income-$15.94M-$15.94M N/M vs Q3 2016N/M vs Q2 2017
EPS Diluted-$0.46-$0.46 N/M vs Q3 2016N/M vs Q2 2017
Operating Income-$15,602,000N/M
Operating Cash Flowderived-$7,981,000N/M
Free Cash Flowderived-$8,535,000N/M
Margins · derived
Operating margin-63.0%+20.2 pt vs Q3 2016
Net margin-64.4%+24.7 pt vs Q3 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $24.75M | $22.19M | $28.64M | $29.64M |
| Net Income | -$15.94M | -$19.79M | -$9.27M | -$13.79M |
| EPS Diluted | -$0.46 | -$0.68 | -$0.32 | -$0.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR